How Tariffs will Impact Localized Production
PharmExec
APRIL 26, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmExec
APRIL 26, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
APRIL 26, 2025
New research confirms hydroxyurea's long-term effectiveness in reducing hospital visits for children with sickle cell anemia, supporting its use as standard treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 26, 2025
You’re reading the web edition of AACR in 30 Seconds, STAT’s guide to the American Association for Cancer Research annual meeting. Sign up for email here. Welcome to STAT’s annual newsletter covering the meeting of the American Association for Cancer Research. We’re glad you’re here. AACR is always a big meeting, usually attended by more than 20,000 doctors, researchers, and industry experts.
The Guardian - Pharmaceutical Industry
APRIL 26, 2025
This weeks oral immunotherapy breakthrough is part of wider surge of interest in developing treatments A severe food allergy is among the few conditions that can propel a person from robust health to unconsciousness within minutes, and the risk of accidental exposure often casts a shadow of anxiety over those affected. But change is afoot, with a groundbreaking trial this week showing that two-thirds of adults with severe peanut allergies can be desensitised through clinically supervised daily e
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
APRIL 26, 2025
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
Let's personalize your content